Mary holds an M.Ed from WWU and has been focused on the study of cannabinoid pharmacology and practical applications for over two decades. She enjoys active collaboration with researchers from various disciplines in cannabis, medicine and education. Mary is dedicated to studying trends in data and patient responses to help guide medical professionals and patients towards developing a greater understanding of the beneficial impacts of purposeful cannabinoid formulations and dosing protocols. She focuses on sharing her expertise at the Advanced Integrative Medical Science Institute in Seattle as well as lecturing through international medical conferences including Cambia Palliative Care Conference, UW; Swedish Oncology Symposium among others.

As a representative of Canvas Therapeutics in Thailand with the MFused Group, Mary plays a key role in providing education to drive policy on the benefits of therapeutic cannabinoids as the country begins to offer CBD legally. Her international work has expanded to Brazil and the Japanese oncology sector where she frequently lectures to physicians, pharmacy boards and patients alike. Driven by her desire for consumers to have access to the highest quality, sustainable medications, she has contributed intellectual property to cannabis formulations as well the development of delivery device technology with companies worldwide.